Holen Sie sich die Stockscreener-App
11.00
0.14%
0.0107
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WBA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Walgreens Boots Alliance Inc Aktie (WBA) Neueste Nachrichten
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline - Walgreens Boots Alliance
Walgreens reaches $300m deal over opioid prescriptions claims - Yahoo Finance
Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline | WBA Stock News - GuruFocus
Jim Cramer on Walgreens (WBA): “Clock’s Ticking on That One” - Insider Monkey
Understanding the Risks of Investing in Walgreens Boots Alliance Inc (WBA) - knoxdaily.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, WBA, RDW on Behalf of Shareholders - PR Newswire
In time for Earth Day, a new pilot aims to further reduce waste in our supply chain - Walgreens Boots Alliance
Walgreens To Pay Up To $350 Mln For Opioid Settlement - RTTNews
Walgreens to settle invalid prescriptions case for $300 million - The Arkansas Democrat-Gazette
Walgreens (WBA) Settles Opioid Prescription Allegations for $350M - GuruFocus
Walgreens to pay $350M in U.S. opioid settlement (WBA:NASDAQ) - Seeking Alpha
Walgreens (WBA) Agrees to $3.5 Billion Settlement Over Opioid Prescriptions - GuruFocus
Walgreens agrees to pay up to $350 million to U.S. government in opioid settlement - MarketWatch
Walgreens to pay $300 million to settle claims it illegally filled invalid opioid prescriptions - KPAX News
Deerfield-based Walgreens to pay $300 million to settle federal allegations of unlawfully filling opioid scripts - Lake and McHenry County Scanner
Long-Term Investors in shares of Walgreens Boots Alliance, Inc. - openPR.com
WBA Stock Quote Price and Forecast - CNN
Sector Update: Health Care - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Walgreens settlement: Pharmacy chain agrees to pay up to $350M for illegally filling unlawful opioid prescriptions - ABC7 Chicago
Walgreens Must Pay Hefty Fine In Opioid CaseWalgreens Boots Alliance (NASDAQ:WBA) - Benzinga
Walgreens to pay $300 million in US opioid settlement - Reuters
Walgreens paying up to $350M as it tries to close the book on opioid lawsuits - Crain's Chicago Business
Walgreens Boots Alliance (WBA) Settles Opioid Prescription Allegations for $300 Million - GuruFocus
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says By Reuters - Investing.com
Walgreens to Pay Up to $350 Million to Settle Claims It Played a Role in the US Opioid Crisis - marketscreener.com
6.5M Pounds of Medications Safely Disposed: Walgreens Leads National Drug Take Back Day 2025 - Stock Titan
Walgreens settles allegations of filling invalid opioid prescriptions for $300 million, US DOJ says - NewsBreak: Local News & Alerts
Boots Workers Worry About Sycamore Cost Cuts - The Business of Fashion
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day this Saturday - Walgreens Boots Alliance
Townsquare Capital LLC Cuts Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Short Interest in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Decreases By 20.2% - Defense World
Walgreens To Pay DOJ $300M Over Invalid Prescriptions - Law360
Walgreens Boots Alliance (WBA) Reaches Settlement with DOJ Over Opioid Dispensing Rules - GuruFocus
Walgreens settles opioid litigation for $300 million - Investing.com
Hanes' CLO Resigns For 'Another Business Opportunity' - Law360
Investors | Global Leaders in Retail Pharmacy | WBA - Walgreens Boots Alliance
Walgreens Boots Alliance (WBA): Strong Industry, Solid Earnings Estimate Revisions - TradingView
6 ways your pharmacist can support your health and wellness - Walgreens Boots Alliance
Wells Fargo & Company MN Has $10.09 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Franklin Resources Inc. Decreases Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Arrowhead Pharma Taps Walgreens Finance Chief to Lead Commercial Stage Transition - Stock Titan
Walgreens: Acquisition Is The Best-Case Scenario For The Company - Seeking Alpha
Sycamore Partners’ plan to takeover Walgreens ‘incredibly risky,’ analyst says - Healthcare Brew
More Walgreens Locations Set to Shut Down in Connecticut This May - NewsBreak: Local News & Alerts
No shortage of egg-inspired options this Easter at Walgreens - Walgreens Boots Alliance
Form PREM14A Walgreens Boots Alliance For: Apr 14 - StreetInsider
Private Equity Firm Acquires Parent Company of Walgreens and Duane Reade - Dark Daily
Walgreens Comeback? Private Equity Circling for a Buyout - MarketBeat
Down 89%, Should You Buy the Dip on Walgreens Boots Alliance? - AOL.com
Walgreens Boots Alliance (WBA) Exceeds Earnings and Revenue Expe - GuruFocus
Robbie Huffines - Walgreens Boots Alliance
'Discipline And Dedication To Excellence' Propelled Rosalind 'Roz' Brewer To Become One Of Few Black Women CEOs In Fortune 500 - AfroTech
What Does the Market Think About Walgreens Boots Alliance? - Benzinga
Inside Walgreens PetShoppe: For pets and their people - Walgreens Boots Alliance
Walgreens Boots Alliance (NASDAQ:WBA) Now Covered by Analysts at StockNews.com - Defense World
Walgreens Boots Alliance: Last Change To Buy (NASDAQ:WBA) - Seeking Alpha
Boots sales nudge up amid Walgreens turnaround plan - Retail Gazette
Walgreens Boots Alliance Q2 2025: sales up 4.1 percent but EPS plummets - Global Cosmetics News
Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down - Zacks Investment Research
Walgreens Boots Alliance sees net loss narrowed in Q2 FY25 - Yahoo Finance
Wisconsin Hit Hard in Walgreens’ Store Closures—See If Your Location Is Affected - NewsBreak: Local News & Alerts
Walgreens Boots Alliance Sees Sales Growth And Earnings Beat - Finimize
Decoding Walgreens Boots Alliance Inc (WBA): A Strategic SWOT Insight - GuruFocus
Walgreens Boots Alliance Reports Q2 Fiscal 2025 Results - TipRanks
9.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):